Carregant...
MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism
BACKGROUND: Glucose metabolic reprogramming is a significant hallmark of malignant tumors including GBM. Previous studies suggest that microRNAs play key roles in modulating this process in GBM cells. miR-181b acts as a tumor suppressor miRNA in influencing glioma tumorigenesis. Our previous results...
Guardat en:
| Publicat a: | Cancer Cell Int |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7057587/ https://ncbi.nlm.nih.gov/pubmed/32158359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-1149-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|